Search Results - "Nesmith, Ken"

Weight Loss Using Evidence-Based Strategies in Mobile Apps by Petakov, Artem, Nesmith, Ken

Get full text

Relationship between immune phenotype and treatment selection of Chemo-IO vs. IO-only in TPS-high NSCLC using hypothetical test-and-control group generation based on survival data extracted from phase III trials by Oum, Chiyoon, Moon, Jimin, Seo, Melody SeungHui, Lim, Yoojoo, Ahn, Chang Ho, Nesmith, Ken, Ock, Chan-Young

“…e13569 Background: Immunotherapy has become the treatment of choice for the first-line treatment of unresectable NSCLC with high PD-L1 tumor proportion score…”
Get full text

Exploring expression levels of HER2, HER3, MET, Claudin18.2, and MUC16 across 16 cancer types using an artificial intelligence-powered immunohistochemistry analyzer by Shin, Seunghwan, Cho, Soo Ick, Choi, Sangjoon, Lee, Taebum, Kim, Seulki, Jung, Wonkyung, Mostafavi, Mohammad, Brattoli, Biagio, Ryu, Jeongun, Park, Seonwook, Pereira, Sergio, Nesmith, Ken, Park, Jiyoung, Seo, Melody SeungHui, Kim, Huijeong, Kim, Seokhwi, Ock, Chan-Young

“…3135 Background: Quantifying tumor-associated antigen (TAA) expression levels on tumor cells (TC) from immunohistochemistry (IHC) stained slides has been…”
Get full text

Early Assessment of Molecular Progression and Response by Whole-genome Circulating Tumor DNA in Advanced Solid Tumors by Davis, Andrew A, Iams, Wade T, Chan, David, Oh, Michael S, Lentz, Robert W, Peterman, Neil, Robertson, Alex, Shah, Abhik, Srivas, Rohith, Wilson, Timothy J, Lambert, Nicole J, George, Peter S, Wong, Becky, Wood, Haleigh W, Close, Jason C, Tezcan, Ayse, Nesmith, Ken, Tezcan, Haluk, Chae, Young Kwang

“…Treatment response assessment for patients with advanced solid tumors is complex and existing methods require greater precision. Current guidelines rely on…”
Get full text

Abstract 2279: Serial changes in tumor-derived whole-genome cfDNA fraction to identify early disease progression prior to imaging by Davis, Andrew A., Iams, Wade T., Chan, David, Oh, Michael S., Lentz, Robert W., Peterman, Neil, Robertson, Alex, Shah, Abhik, Srivas, Rohith, Lambert, Nicole, Wilson, Tim, George, Peter, Wong, Becky, Tezcan, Ayse, Yalamanchili, Ram, Nesmith, Ken, Spinosa, John C., Tezcan, Haluk, Chae, Young Kwang

“…Abstract Background: Response to cancer treatment is usually determined by clinical exam and imaging assessment. Here, we analyzed changes in tumor-derived…”
Get full text

Whole-genome cell-free DNA (cfDNA) changes as a dynamic blood-based biomarker for early response assessment of advanced tumors by Davis, Andrew A., Iams, Wade Thomas, Chan, David, Oh, Michael S, Lentz, Robert William, Peterman, Neil, Robertson, Alex, Shah, Abhik, Srivas, Rohith, Lambert, Nicole, Wilson, Timothy, George, Peter, Wong, Becky, Tezcan, Ayse, Yalamanchili, Ram, Nesmith, Ken, Spinosa, John C, Tezcan, Haluk, Chae, Young Kwang

“…Abstract only 3041 Background: Liquid biopsies have potential clinical utility as dynamic biomarkers for treatment response. We analyzed serial changes in…”
Get full text

A prospective study tracking longitudinal changes in genome-wide cell-free DNA (cfDNA) methylation to identify early nonresponders to cancer treatment by Davis, Andrew A., Iams, Wade Thomas, Chan, David, Oh, Michael S, Lentz, Robert William, Srivas, Rohith, Lambert, Nicole, Robertson, Alex, Peterman, Neil, Shah, Abhik, Wilson, Timothy, Close, Jason, George, Peter, Wood, Haleigh, Tezcan, Ayse, Yalamanchili, Ram, Nesmith, Ken, Spinosa, John C, Tezcan, Haluk, Chae, Young Kwang

“…Abstract only 3042 Background: Methylation is an epigenetic modification linked to cancer pathogenesis. The aim was to determine if changes in cfDNA…”
Get full text

961 Tumor-infiltrating lymphocytes in tumor microenvironment assessed by artificial intelligence powered H&E image analyzer is correlated with immunomodulatory subtype of triple-negative breast cancer by Moon, Jimin, Ahn, Chang Ho, Shin, Seunghwan, Kim, Seulki, Lee, Taebum, Cho, Soo Ick, Lim, Yoojoo, Kang, Mingu, Song, Heon, Yoo, Donggeun, Nesmith, Ken, Ali, Siraj, Ock, Chan-Young, Kim, Seokhwi

“…BackgroundTumor-infiltrating lymphocytes (TILs) serve as both prognostic and predictive biomarker in triple-negative breast cancer (TNBC). TNBC exhibits six…”
Get full text

961 Tumor-infiltrating lymphocytes in tumor microenvironment assessed by artificial intelligence powered H E image analyzer is correlated with immunomodulatory subtype of triple-negative breast cancer by Chan-Young Ock, Seulki Kim, Siraj Ali, Soo Ick Cho, Seunghwan Shin, Yoojoo Lim, Heon Song, Donggeun Yoo, Taebum Lee, Mingu Kang, Chang Ho Ahn, Jimin Moon, Ken Nesmith, Seokhwi Kim

Get full text

Abstract 5389: Micron-resolution spatial analysis near the tumor-stromal border reveals a distinct density distribution of tumor-infiltrating lymphocytes and related genomic features by Song, Sanghoon, Park, Gahee, Kim, Sukjun, Choi, Sangjoon, Kim, Seokhwi, Jung, Wonkyung, Kang, Mingu, Mostafavi, Mohammad, Song, Heon, Valero, Aaron, Pereira, Sérgio, Yoo, Donggeun, Kim, Seulki, Shin, Seunghwan, Nesmith, Ken, Ock, Chan-Young

“…Abstract Tumor-infiltrating lymphocytes (TILs) play a major role in predicting response to immunotherapy in solid tumors. However, few studies have analyzed…”
Get full text